Iversen Tor, Aas Eline, Rosenqvist Gunnar, Häkkinen Unto
Department of Health Management and Health Economics, University of Oslo, Oslo, Norway.
Hanken School of Economics, Helsinki, Finland.
Health Econ. 2015 Dec;24 Suppl 2:5-22. doi: 10.1002/hec.3262.
This study examines the challenges of estimating risk-adjusted treatment costs in international comparative research, specifically in the European Health Care Outcomes, Performance, and Efficiency (EuroHOPE) project. We describe the diverse format of resource data and challenges of converting these data into resource use indicators that allow meaningful cross-country comparisons. The three cost indicators developed in EuroHOPE are then described, discussed, and applied. We compare the risk-adjusted mean treatment costs of acute myocardial infarction for four of the seven countries in the EuroHOPE project, namely, Finland, Hungary, Norway, and Sweden. The outcome of the comparison depends on the time perspective as well as on the particular resource use indicator. We argue that these complementary indicators add to our understanding of the variation in resource use across countries.
本研究探讨了在国际比较研究中估算风险调整治疗成本的挑战，特别是在欧洲医疗保健结果、绩效和效率（EuroHOPE）项目中。我们描述了资源数据的多样格式以及将这些数据转换为可进行有意义的跨国比较的资源使用指标所面临的挑战。然后介绍、讨论并应用了EuroHOPE项目中开发的三个成本指标。我们比较了EuroHOPE项目七个国家中四个国家（即芬兰、匈牙利、挪威和瑞典）急性心肌梗死的风险调整平均治疗成本。比较结果取决于时间视角以及特定的资源使用指标。我们认为这些互补指标有助于我们理解各国资源使用的差异。
